MYB and leukemia: Taken together, this suggests that MYB normally supports the leukaemia phenotype in MLL-rearranged AML by directly or indirectly limiting MAFB expression, with the additional possibility of suppression of MAFB protein activity, thereby limiting the ability of the cells to differentiate.